(Q44851391)
Statements
1 reference
Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study). (English)
1 reference
1 reference
Montserrat Lonca
1 reference
Jose M Gatell
1 reference
EfaVIP Cohort Study Group
1 reference
Jose M Miró
1 reference
María A Costa
1 reference
Juan González
1 reference
Rafael Rubio
1 reference
Jose M Peña
1 reference
Alicia Lorenzo
1 reference
Concepcion Cepeda
1 reference
Juan J Vázquez
1 reference
1 April 2004
1 reference
1 reference
35
1 reference
4
1 reference
343-350
1 reference
Identifiers
1 reference
1 reference